Dr Evangelos Russo completed his medical training at University College London in 2003. Until 2008 he undertook general medical training in Hertfortshire, Kent and Hammersmith hospitals. In 2008 he joined the north west Thames rotation as a registrar in gastroenterology where he remained until 2016. During that time he also completed a PhD in translational medicine at Imperial College with a focus on imaging in Crohn’s disease.
He was appointed consultant gastroenterologist at Imperial College Healthcare NHS Trust in January 2017.
Dr Russo has a strong research interest in inflammatory bowel disease.
Additional languages spoken: French, Greek
HIs publications include:
EA Russo, SA Khan, R Janisch, RN Gunn, EA Rabiner, SA Taylor, PM Matthews, TR Orchard. The role of 18F-fluorodeoxyglucose positron emission tomography in the monitoring of inflammatory activity in Crohn’s disease. Inflamm Bowel Dis 2016 – In press
A Plumb, A Menys, EA Russo, D Prezzi, G Bhatnagar, R Vega, S Halligan, TR Orchard, SA Taylor. Magnetic resonance imaging-quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn’s disease. Aliment Pharmacol Ther. 2015 Aug;42(3):343-55
P Kennedy, EA Russo, N Kumar, N Powell, P Vlavianos, A Thillainayagam, D Bansi, D Westaby. Effectiveness of prophylactic pancreatic stents in preventing post-ERCP pancreatitis: A two-year retrospective controlled study in a tertiary centre in London.
Surg Endosc. 2010 Aug;24(8):1923-8
EA Russo, M Iacucci, JO Lindsay, S Campbell, JP Hamlin, TR Orchard, N Arebi, AL Hart, SM Gabe, MR Jacyna, J Nightingale, M O’Connor, AW Harris, C O’Morain, S Ghosh.
Survey regarding the use of adalimumab as maintenance therapy in Crohn’s disease in England and Ireland.
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):334-9.
EA Russo, AW Harris, S Campbell, J Lindsay, A Hart, N Arebi, A Milestone, HH Tsai, J Walters, M Carpani, D Westaby, A Thillainayagam, D Bansi, S Ghosh.
Experience of maintenance infliximab therapy for refractory ulcerative colitis in England.
Aliment Pharmacol Ther. 2009 Feb 1;29(3):308-14.